A nationally recognized leader in diabetes care and innovation, Dr. Robert A. Gabbay is an associate professor at Harvard Medical School and a former Chief Scientific and Medical Officer of the American Diabetes Association. He has led transformative efforts in primary care, technology, and patient-centered tools that shape how diabetes is managed today—making him a trusted voice on how to choose the right tech for real life.

Amy is a pioneering diabetes advocate, journalist, and founder of DiabetesMine, one of the most influential platforms in the diabetes community. Living with type 1 diabetes herself, she has spent two decades connecting patients, innovators, and clinicians to improve diabetes technology. Known for translating complex tools into real-world insights, Amy brings a powerful, lived-experience perspective to choosing what truly works.

Dr. Viril N. Shah is a leading endocrinologist, researcher, and Professor of Medicine at Indiana University, specializing in diabetes technology and clinical care. As a principal investigator on landmark trials that helped bring new devices to market, he offers deep expertise on what works, for whom, and why—helping people confidently navigate today’s rapidly evolving diabetes tech landscape.

Dr. McVean is a pediatric endocrinologist and Senior Medical Affairs Director at MiniMed with nearly 20 years of experience. Living with type 1 diabetes herself, she brings both personal insight and clinical expertise. She has led research and development in insulin delivery and automated systems, published in leading journals, and helps families and clinicians choose the right diabetes technology with confidence.